Betsy Fishbone - 01 Jun 2026 Form 3 Insider Report for COLGATE PALMOLIVE CO (CL)

Reporting relationship: CLO and Secretary
Issuer ticker: CL
Reported as of: 01 Jun 2026
Net transaction value: $0
SEC form: 3
Accepted by SEC: 05 Jun 2026, 16:13:21 UTC
Source filing: View source filing
Reporting owner signature: /s/ Kristine Hutchinson, Attorney-in-Fact

Key filing fact

Betsy Fishbone filed Form 3 for COLGATE PALMOLIVE CO (CL) on 05 Jun 2026.

Key facts

This page summarizes Betsy Fishbone's Form 3 filing for COLGATE PALMOLIVE CO (CL).
0 reported transactions and 5 derivative rows are listed below.
Accepted by SEC: 05 Jun 2026, 16:13.

Change

No earlier filing in this sequence is available for direct comparison.
Current net transaction value: $0.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Official SEC source

Ownership activity is grounded in SEC Form 3 disclosures.

View source filing

Reporting Owners (1)

CIK 0002132341 Primary reporting owner

Fishbone Betsy

Relationship: CLO and Secretary
Address: C/O COLGATE-PALMOLIVE COMPANY, 300 PARK AVENUE, NEW YORK
Signature: /s/ Kristine Hutchinson, Attorney-in-Fact
Signature date: 05 Jun 2026

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

CL holding

Common Stock

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after: 15,021
Date: 01 Jun 2026
Ownership: Direct

CL holding

Common Stock

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after: 50
Date: 01 Jun 2026
Ownership: By Family Member

CL holding

Common Stock

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after: 8,336
Date: 01 Jun 2026
Ownership: By Issuer's 401(k) Plan Trustee

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

CL holding Derivative

Stock Option (Right to Buy)

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after
Date: 01 Jun 2026
Ownership: Direct
Underlying class: Common Stock
Underlying amount: 9,944
Exercise price: $72.83
Footnotes: F1

CL holding Derivative

Stock Option (Right to Buy)

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after
Date: 01 Jun 2026
Ownership: Direct
Underlying class: Common Stock
Underlying amount: 19,012
Exercise price: $77.04
Footnotes: F2

CL holding Derivative

Stock Option (Right to Buy)

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after
Date: 01 Jun 2026
Ownership: Direct
Underlying class: Common Stock
Underlying amount: 16,612
Exercise price: $78.03
Footnotes: F3

CL holding Derivative

Stock Option (Right to Buy)

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after
Date: 01 Jun 2026
Ownership: Direct
Underlying class: Common Stock
Underlying amount: 9,392
Exercise price: $84.06
Footnotes: F4

CL holding Derivative

Stock Option (Right to Buy)

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after
Date: 01 Jun 2026
Ownership: Direct
Underlying class: Common Stock
Underlying amount: 6,848
Exercise price: $106.34
Footnotes: F5

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 5 footnotes

Footnote F1

Option became exercisable in one-third increments beginning on the first anniversary of the September 13, 2023 grant date.

Footnote F2

Option became exercisable in one-third increments beginning on the first anniversary of the September 10, 2021 grant date.

Footnote F3

Option became exercisable in one-third increments beginning on the first anniversary of the September 9, 2022 grant date.

Footnote F4

Option becomes exercisable in one-third increments beginning on the first anniversary of the September 11, 2025 grant date.

Footnote F5

Option became exercisable in one-third increments beginning on the first anniversary of the September 12, 2024 grant date.

SEC remarks

Exhibit 24 - Power of Attorney

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. to update or revoke optional consent for future visits. For more information, see our Privacy Policy .